Emmet Jordan

11.1k total citations · 1 hit paper
42 papers, 1.2k citations indexed

About

Emmet Jordan is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Emmet Jordan has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Emmet Jordan's work include Cancer Genomics and Diagnostics (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Emmet Jordan is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Emmet Jordan collaborates with scholars based in United States, Ireland and Puerto Rico. Emmet Jordan's co-authors include David B. Solit, Michael F. Berger, Ahmet Zehir, Maeve A. Lowery, David M. Hyman, Ghassan K. Abou‐Alfa, Maria E. Arcila, Eileen M. O’Reilly, James J. Harding and Nancy E. Kemeny and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Emmet Jordan

39 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention

2018 369 citations Maeve A. Lowery, Ryan Ptashkin et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Emmet Jordan

Since Specialization

Citations

This map shows the geographic impact of Emmet Jordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmet Jordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmet Jordan more than expected).

Fields of papers citing papers by Emmet Jordan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmet Jordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmet Jordan. The network helps show where Emmet Jordan may publish in the future.

Co-authorship network of co-authors of Emmet Jordan

This figure shows the co-authorship network connecting the top 25 collaborators of Emmet Jordan. A scholar is included among the top collaborators of Emmet Jordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmet Jordan. Emmet Jordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review 2023 ·Biochemistry and Biophysics Reports ·(unknown), (unknown), Emmet Jordan, Órla O’Donovan, Edel A. McNeela, Jai Prakash Mehta, Sweta Rani	10
2	Systemic anti-cancer therapy in older patients with gastrointestinal malignancies following comprehensive geriatric assessment: An age-based subgroup analysis. 2023 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), Emmet Jordan, Paula Calvert, Miriam O’Connor, Anne M. Horgan	1
3	The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors 2022 ·Irish Journal of Medical Science (1971 -) ·William Mullally, John Greene, Emmet Jordan, Anne M. Horgan, Miriam O’Connor, Paula Calvert	4
4	Adenoid cystic carcinoma of the prostate – A rare case of genitourinary malignancy 2022 ·Urology Case Reports ·Paul Ryan, (unknown), (unknown), Emmet Jordan, John Keane, Pádraig Daly	1
5	AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin Signaling 2020 ·Molecular Cancer Research ·Sizhi Paul Gao, (unknown), Kai Zhang, Naresh Vasani, Ninghui Mao, Emmet Jordan, (unknown), Tripti Shrestha Bhattarai, Wenhuo Hu, M. Dorso, (unknown), Kwanghee Kim, Aphrothiti J. Hanrahan, Pedram Razavi, Brett S. Carver, Sarat Chandarlapaty, Jorge S. Reis‐Filho, Barry S. Taylor, David B. Solit	12
6	Maintaining a Medical Oncology Service during the Covid-19 Pandemic. 2020 ·PubMed ·John Greene, William Mullally, Yasar Ahmed, Muhammad Shoaib Khan, Paula Calvert, Anne M. Horgan, Emmet Jordan, (unknown)	1
7	Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance 2018 ·Clinical Cancer Research ·Helena A. Yu, Ken Suzawa, Emmet Jordan, Ahmet Zehir, Ai Ni, Hyunjae R. Kim, Mark G. Kris, Matthew D. Hellmann, Bob T. Li, Romel Somwar, David B. Solit, Michael F. Berger, Maria E. Arcila, Gregory J. Riely, Marc Ladanyi	188
8	Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype–Phenotype Features—An Entity With an Increasing Incidence? 2018 ·Clinical Colorectal Cancer ·Emmet Jordan, Maeve A. Lowery, Olca Baştürk, Peter J. Allen, Kenneth H. Yu, Viviane Tabar, Kathryn Beal, Diane Reidy‐Lagunes, Yoshiya Yamada, Yelena Y. Janjigian, Ghassan K. Abou‐Alfa, Eileen M. O’Reilly	14
9	Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention breakdown → 2018 ·Clinical Cancer Research ·Maeve A. Lowery, Ryan Ptashkin, Emmet Jordan, Michael F. Berger, Ahmet Zehir, Marinela Capanu, Nancy E. Kemeny, Eileen M. O’Reilly, Imane El-Dika, William R. Jarnagin, James J. Harding, Michael I. D’Angelica, Andrea Cercek, Jaclyn F. Hechtman, David B. Solit, Nikolaus Schultz, David M. Hyman, David S. Klimstra, Leonard B. Saltz, Ghassan K. Abou‐Alfa	369
10	DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma 2017 ·Clinical Cancer Research ·Min Yuen Teo, Richard Bambury, Emily C. Zabor, Emmet Jordan, Hikmat Al‐Ahmadie, Mariel Elena Boyd, Nancy Bouvier, Stephanie A. Mullane, K. Eugene, Nitin Roper, Irina Ostrovnaya, David M. Hyman, Bernard H. Bochner, Maria E. Arcila, David B. Solit, Michael F. Berger, Dean F. Bajorin, Joaquim Bellmunt, Gopa Iyer, Jonathan E. Rosenberg	189
11	Case report: primary acinar cell carcinoma of the liver treated with multimodality therapy 2017 ·Journal of Gastrointestinal Oncology ·Emmet Jordan, Olca Baştürk, Jinru Shia, David S. Klimstra, William Alago, Michael I. D’Angelica, Ghassan K. Abou‐Alfa, Eileen M. O’Reilly, Maeve A. Lowery	6
12	Clinical and Molecular Analysis of Adenosquamous Carcinoma of the Pancreas 2016 ·JOP, journal of the pancreas ·Emmet Jordan, Olca Baştürk, Steven D. Leach, David S. Klimstra, Peter J. Allen, Michael F. Berger, Gokce Askan, Christine A. Iacobuzio–Donahue, Kenneth H. Yu, (unknown), Maeve A. Lowery	1
13	Urachal Carcinoma Shares Genomic Alterations with Colorectal Carcinoma and May Respond to Epidermal Growth Factor Inhibition 2016 ·European Urology ·Ana Collazo-Lorduy, Mireia Castillo-Martín, Li Wang, Vaibhav G. Patel, Gopa Iyer, Emmet Jordan, Hikmat Al‐Ahmadie, (unknown), William Oh, Jun Zhu, Russell B. McBride, Carlos Cordon‐Cardo, David B. Solit, John P. Sfakianos, Matthew D. Galsky	63
14	Systemic therapy for biliary cancers 2016 ·Chinese Clinical Oncology ·Emmet Jordan, Ghassan K. Abou‐Alfa, Maeve A. Lowery	11
15	Targeted Therapy in Advanced Bladder Cancer 2015 ·Urologic Clinics of North America ·Emmet Jordan, Gopa Iyer	13
16	Association of somatic mutations in DNA damage repair (DDR) genes with efficacy of platinum-based chemotherapy in advanced urothelial carcinoma. 2015 ·Journal of Clinical Oncology ·Richard Bambury, Emmet Jordan, Emily C. Zabor, Nancy Bouvier, Hikmat Al‐Ahmadie, Mariel Elena Boyd, Stephanie A. Mullane, K. Eugene, Irina Ostrovnaya, David M. Hyman, Bernard H. Bochner, Maria E. Arcila, David B. Solit, Dean F. Bajorin, Joaquim Bellmunt, Michael F. Berger, Gopa Iyer, Jonathan E. Rosenberg	3
17	Vemurafenibfor the treatment of melanoma 2012 ·Expert Opinion on Pharmacotherapy ·Emmet Jordan, Catherine M. Kelly	26
18	Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma. 1994 ·Journal of Clinical Oncology ·Jean L. Grem, Nanette McAtee, Robert F. Murphy, J. Michael Hamilton, Frank M. Balis, Seth M. Steinberg, Susan G. Arbuck, Ann Setser, Emmet Jordan, (unknown)	34
19	[Remote results of clinical observation of the oncolytic action of adenoviruses on cervix cancer]. 1970 ·PubMed ·Tomasz Zieliński, Emmet Jordan	8
20	Research on the oncolytic effect of APC viruses in cancer of the cervix uteri; preliminary report. 1959 ·PubMed ·J Georgiades, Tomasz Zieliński, (unknown), Emmet Jordan	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact